Comparison of Bone Effects With Copaxone and Interferon in Multiple Sclerosis

• Status: Completed
• Trial end date: 2012-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to determine if certain drugs commonly used to treat multiple sclerosis have an effect on bone health.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Nancy Hammond, MD
• Collaborator: Kansas City Area Life Sciences Institute, Inc.
• Treatments: (T,G)-A-L; Glatiramer Acetate; Interferon beta-1a; Interferon beta-1b; Interferon-beta; Interferons

Criteria

Inclusion Criteria:

• Female, age > 18

• Able to understand and give informed consent

• Relapsing remitting multiple sclerosis (RRMS)

• Treatment with interferons or Copaxone for at least one year prior to study entry

Exclusion Criteria:

• Known osteoporosis

• History of hypercalcemia

• Currently pregnant

• History of primary hyperparathyroidism, hyperthyroidism, or hypothyroidism

• Unstable medical condition

• Ongoing use of bisphosphonates